大肠杆菌精氨酰—tRNA合成酶的变种ArgRS306KR的纯化…

本文从含ＡｒｇＲＳ３０６ＫＲ基因ａｒｇｓ３０６ＫＲ的ｐＵＣ１８重组质粒的大肠杆菌ＴＧ１转化子中经ＤＥＡＥ－Ｓｅｐｈａｃｅｌ和Ｂｌｕｅ－Ｓｅｐｈａｒｏｓｅ两步柱层析,得到电泳一条带的ＡｒｇＲＳ３０６ＫＲ。纯酶的比活为２７９０单位／毫克。该酶氨酰化和ＡＴＰ－ＰＰｉ交换活力的最适ＰＨ分别为ＰＨ８．３和ＰＨ７．５。氨酰化活力对ＡＴＰ、Ａｒｇ和ｔＲＮＡ的Ｋｍ分别２．６ｍｍｏｌ／Ｌ、１４．０μｍｏｌ／Ｌ和５．     

大肠杆菌精氨酰－tRNA合成酶变种ArgRS381KA的基本性质

本文研究了Ｌｙｓ３８１变为Ａｌａ的精氨酰－ｔＲＮＡ合成酶（ＡｒｇＲＳ）变种ＡｒｇＲＳ３８１ＫＡ的最适ｐＨ和稳态动力学性质;比较了此酶与天然酶ＡｒｇＲＳ的荧光光谱性质和热稳定性。实验结果表明ＡｒｇＲＳ３８１ＫＡ的氨酰化活力和ＡＴＰ￣ＰＰｉ交换活力的最适ｐＨ分别为８．０和７．０,与天然酶相同;ＡｒｇＲＳ３８１ＫＡ的氨酰化活力对精氨酸、ＡＴＰ和ｔＲＮＡＡｒｇ的Ｋｍ分别为１２μｍｏｌ／Ｌ、０．３ｍｍｏｌ／Ｌ和１．１μｍｏｌ／Ｌ,Ｖｍａｘ为１６０００Ｕ／ｍｇ,ｋｃａｔ为１６ｓ－１;ＡＴＰ￣ＰＰｉ交换活力对精氨酸、ＡＴＰ和ＰＰｉ的Ｋｍ分别为９２．９μｍｏｌ／Ｌ、０．８５ｍｍｏｌ／Ｌ和８０．１μｍｏｌ／Ｌ,Ｖｍａｘ为２８０００～３００００Ｕ／ｍｇ,ｋｃａｔ为３２ｓ－１．ＡｒｇＲＳ３８１ＫＡ的荧光激发光谱和发射光谱与ＡｒｇＲＳ基本相同。热失活速度比天然酶慢。     

大肠杆菌精氨酰—tRNA合成酶变种ArgRS381KA的基本性质

本文研究了Ｌｙ３８１变为Ａｌａ的精氨酰－ｔＲＮＡ合成酶（ＡｒｇＲＳ）变种ＡｒｇＲＳ３８１ＫＡ的最适ｐＨ和稳态动力学性质;比较了此酶与天然酶ＡｒｇＲＳ的荧光光谱性质和热稳定性。实验结果表明ＡｒｇＲＳ３８１ＫＡ的氨酰化活力和ＡＴＰ￣ＰＰｉ交换活力的最适ｐＨ分别为８．０和７．０,与天然酶相同;ＡｒｇＲＳ３８１ＫＡ的氨酰化活力对精氨酸、ＡＴＰ和ｔＲＮＡ＾Ａｒｇ的Ｋｍ分别为１２μｍｏｌ／Ｌ、０．３ｍｍｏｌ／     

大肠杆菌精氨酰－tRNA合成酶的Lys306为酶活力所必需

将大肠杆菌精氨酰ｔＲＮＡ合成酶（ＡｒｇＲＳ）上Ｌｙｓ３０６用基因点突变的方法分别变为Ａｌａ和Ａｒｇ的密码子;得到变种基因ａｒｇｓ３０６ＫＡ和ａｒｇｓ３０６ＫＲ。变种基因重组在ｐＵＣ１８上,转化到大肠杆菌ＴＧ１中,转化子中ＡｒｇＲＳ及其变种ＡｒｇＲＳ３０６ＫＡ和ＡｒｇＲＳ３０６ＫＲ所表达的蛋白量至少为ＴＧ１表达ＡｒｇＲＳ蛋白量的１００倍。细胞粗抽提液中ＡｒｇＲＳ的比活ＴＧ１、转化子ｐＵＣ１８－ａｒｇｓ、ｐＵＣ１８－ａｒｇｓ３０６ＫＡ和ｐＵＣ１８－ａｒｇｓ３０６ＫＲ分别为１．６５、２１０、１．８和３８单位／毫克。结果表明ＡｒｓＲＳ的Ｌｙｓ３０６为Ａｌａ取代使活力完全丧失;若被Ａｒｇ取代,则活力丧失８０％以上。Ｌｙｓ３０６为ＡｒｇＲＳ活力所必需。     

大肠杆菌亮氨酰－tRNA合成酶LeuRS67R的纯化及其动力学研究

本实验室已得到的亮氨酰－ｔＲＮＡ合成酶（ＬｅｕＲＳ）基因,与文献相比,６７位氨基酸残基由Ｈｉｓ变为Ａｒｇ,此酶被定名为ＬｅｕＲＳ６７Ｒ。我们从该基因与ｐＵＣ１９重组质粒的大肠杆菌ＴＧ１转化子ＴＧ１－９１中得到ＬｅｕＲＳ的高表达,粗抽液中ＬｅｕＲＳ的表达量在转化子中比在宿主菌ＴＧ１中高２０倍以上。用三步拉层析得到电泳一条带的酶,其比活为１７８９单位／毫克。测定其动力学常数,氨酰化活力对Ｌｅｕ、ＡＴＰ的Ｋｍ值分别为０．０２７ｍｍｏｌ／Ｌ、０．４７ｍｍｏｌ／Ｌ,Ｋｃａｔ值分别为３．５～５．１ｓ－１。ＡＴＰ－ＰＰｉ交换活力对Ｌｅｕ、ＡＴＰ的Ｋｍ值分别为０．０３ｍｍｏｌ／Ｌ、１．０ｍｍｏｌ／Ｌ,Ｌｃａｔ值分别为１４０～１５５ｓ－１。此结果与从野生型大肠杆菌Ｋ－１２中提纯的ＬｅｕＲＳ的动力学常数差别很小,６７位氨基酸残基在与活性中心无直接关系的域可能是大肠杆菌的种间差异。     

大肠杆菌精氨酰—tRNA合成酶的Lys306为酶活力所必需

将大肠杆菌精氨酰ｔＲＮＡ合成酶（ＡｒｇＲＳ）上Ｌｙｓ３０６用基因点突变的方法分别变为Ａｌａ和Ａｒｇ的密码子,得到变种基因ａｒｇｓ３０６ＫＡ和ａｒｇｓ３０６ＫＲ。变种基因重组在ｐＵＣ１８上,转化到大肠杆菌ＴＧ１中,转化子中ＡｒｇＲＳ及其变种ＡｒｇＲＳ３０６ＫＡ和ＡｒｇＲＳ３０６ＫＲ所表达的蛋白量生活为ＴＧ１表达ＡｒｇＲＳ蛋白量的１００倍。细胞粗抽提液中ＡｒｇＲＳ的比活ＴＧ１,转化子ｐＵＣ１８－ａｒｇ     

大肠杆菌精氨酰—tRNA合成酶高表达条件的优化及酶…

控制培养基中氨苄青霉素的用量、ＰＨ和培养时间,从含Ｅ．ｃｏｌｉ ａｒｇｓ变种ＡＲＧＳ３８１ＫＡ的Ｅ．ｃｏｌｉ ＴＧ１转化子中,得到了Ｅ．ｃｏｌｉ ＡｒｇＲＳ变种ＡｒｇＲＳ３８１ＫＡ的高表达。从２升培养液中得到１５克湿菌体,粗抽液中ＡｒｇＲＳ３８１ＫＡ的比活为５０３单位／毫克。经过两次ＤＥＡＥ－Ｓｅｐｈａｃｅｌ柱层析,在４天时间内,可得到７８毫克电泳一条的纯酶,活力回收达８０％。该方法可以作为从含ａ     

大肠杆菌JM83精氨酰—tRNA合成酶基因的克隆,测序及表达

用聚合酶链反应（ＰＣＲ）以大肠杆菌ＪＭ８３基因组ＤＮＡ为模板,扩增了精氨酰ｔ－ＲＮＡ合成酶基因,将该基因重组到载体ｐＵＣ１８上转化到大肠杆菌ＴＧ１中,得到在转化子中ＡｒｇＲＳ的高表达。精抽液中ＡｒｇＲＳ的氨酰化活力,ＴＧ１和ＴＧ１转化子分别为１．６５Ｕ／ｍｇ。后者为前者的１２７倍,ＤＮＡ顺序测定表明,与从大肠杆菌ＪＡ２００中克隆到的ＡｒｇＲＳ基因相比９１３位碱基为Ａ而不为Ｃ,这种变化使ＡｒｇＲＳ的     

大肠杆菌精氨酰－tRNA合成酶（ArgRS）及其变种的光谱学研究

本文用吸收光谱、溶剂微扰差光谱荧光光谱和ＣＤ光谱对天然酶ＡｒｇＲＳ及其变种酶ＡｒｇＲＳ３０６ＫＲ和ＡｒｇＲＳ３８１ＫＡ的构象进行了研究,结果表明Ｌｙｓ３０６的突变引起变种酶分子表面的生色氨基酸残基所处微环境与天然酶梢有不同,ＡｒｇＲＳ３０６ＫＡ比ＡｒｇＲＳ３０６ＫＲ有更大的构象变化。变种酶ＡｒｇＲＳ３８１ＫＡ与天然酶的构象差别不大。ＣＤ光谱的分析显示转角在变种酶分子中依活力的下降二级结构中所占百分比下降。可以得出结论ＡｒｇＲＳ的Ｌｙｓ３０６所带的正电荷对维系ＡｒｇＲＳ的构象绝对重要,这种酶的构象变化引起变种酶的活力丧失;而ＡｒｇＲＳ的Ｌｙｓ３８１的改变则似乎不能引起酶构象的可觉察的变化。     

大肠杆菌精氨酰—tRNA合成酶（ArgRS）及其变种的光谱…

本文用吸收光谱，溶剂微据差光谱，荧光光谱和ＣＤ光谱对天然酶ＡｒｇＲＳ及其变种酶ＡｒｇＲＳ３０６ＫＡ，ＡｒｇＲＳ３０６ＫＲ和ＡｒｇＲＳ３８１ＫＡ的构象进行了研究。结果表明Ｌｙｓ３０６的突变引起变种酶分子表面的生色氨基酸残然的处微环境与天然酶稍有不同，ＡｒｇＲＳ３０６ＫＡ比ＡｒｇＲＳ３０６ＫＲ有更大的构象变化。     

Translational control inE. coli: The case of threonyl-tRNA synthetase

Genetic studies have shown that expression of theE. coli threonyl-tRNA synthetase (thrS) gene is negatively auto-regulated at the translational level. A region called the operator, located 110 nucleotides downstream of the 5 end of the mRNA and between 10 and 50bp upstream of the translational initiation codon in thethrS gene, is directly involved in that control. The conformation of anin vitro RNA fragment extending over thethrS regulatory region has been investigated with chemical and enzymatic probes. The operator locus displays structural similarities to the anti-codon arm of threonyl tRNA. The conformation of 3 constitutent mutants containing single base changes in the operator region shows that replacement of a base in the anti-codon-like loop does not induce any conformational change, suggesting that the residue concerned is directly involved in regulation. However mutation in or close to the anti-codon-like stem results in a partial or complete rearrangement of the structure of the operator region. Further experiments indicate that there is a clear correlation between the way the synthetase recognises each operator, causing translational repression, and threonyl-tRNA.     

Enzymatic biosynthesis of ergotamine and investigation on some aminoacyl-tRNA synthetases in Claviceps

An enzyme system from Claviceps purpurea (Fr.) Tul. catalyzing the incorporation of l-phenylalanine into ergotamine - ergotamine synthetase - was purified 172-fold. This was done by a combination of ammonium sulfate precipitation, gel filtration, ion-exchange chromatography on DEAE-Sepharose CL-6B, and hydroxyapatite chromatography. The activation of ergotamine specific amino acids as well as d-lysergic acid and dihydrolysergic acid via adenylates, as determined by the ATP-³²PP_i exchange, was investigated. Phenylalanyl-tRNA synthetase, catalyzing the same type of activation reaction, could not be separated from ergotamine synthetase by the purification procedure applied. Therefore, at the present stage of enzyme purification, phenylalanine-dependent ATP-³²PP_i exchange cannot be used to measure ergotamine synthetase activity specifically.Phenylalanyl-tRNA synthetase and leucyl-tRNA synthetase were separated into mitochondrial and cytoplasmic isoenzymes by hydroxyapatite chromatography. Their charging activities of procaryotic versus eucaryotic tRNA and their molecular masses were determined.     

Electrophoretic assay of folylpolyglutamate synthetase activity

A method is described for the determination of the activity of folylpolyglutamate synthetase based upon incorporation of reaction products into a covalent, ternary complex with tritiated 5-fluoro-2′-deoxyuridylate and thymodylate synthetase followed by electrophoretic identification of the enzyme-bound polyglutamate species.     

氨基酰-tRNA合成酶与神经退行性疾病

氨基酰-tRNA合成酶催化tRNA的氨基酰化反应为生物体内的蛋白质合成提供原料.这类古老且保守的蛋白质分子在高等生物复杂的细胞分子网络中分化出的新功能是目前人们关注的焦点.近期在对一些患有神经退行性疾病的病人和小鼠模型的研究中发现,位于酪氨酰-tRNA合成酶、甘氨酰-tRNA合成酶和丙氨酰-tRNA合成酶上的突变,可分别导致DI腓骨肌萎缩症(Charcot-Marie-Toothdisease,CMT)C型,腓骨肌萎缩症2D型及小脑浦肯雅(Purkinje)细胞丢失.初步的致病机理研究表明,致病突变对这3种酶的影响各不相同:酪氨酰-tRNA合成酶的氨基酰化催化能力受到影响,甘氨酰-tRNA合成酶受影响的可能是一种未知的新功能,而丙氨酰-tRNA合成酶受影响的则是它的编校功能.这些研究结果揭示了氨基酰-tRNA合成酶涉及神经退行性疾病的广泛性和其机制的复杂性,并将促进对神经退行性疾病这一类常见疾病的病理和治疗方法的研究.     

Effect of starvation on the N-acetylglutamate system of rat liver

Hydrogenase gene from Clostridium butyricum was cloned in Escherichia coli HK16 (Hyd-) using pBR322 and PstI. The plasmid, pCBH1, containing hydrogenase gene was 7.3 MDa and pCBH1 had 5 PstI-DNA fragments (3.9, 2.6, 0.7, 0.03-0.04, less than 0.02 MDa, respectively). The hydrogenase activity of HK16 (pCBH1) was about 3.1-3.5-times as high as those of the present strains, such as C.butyricum and E.coli C600 (Hyd+).     

A spectrophotometric assay of gamma-glutamylcysteine synthetase and glutathione synthetase in crude extracts from tissues and cultured mammalian cells

An assay of gamma-glutamylcysteine synthetase (gamma-GCS) and glutathione synthetase (GS) in crude extracts of cultured cells and tissues is described. It represents a novel combination of known methods, and is based on the formation of glutathione (GSH) from cysteine, glutamate and glycine in the presence of rat kidney GS for the assay of gamma-GCS, or from gamma-glutamylcysteine and glycine for the assay of GS. GSH is then quantified by the Tietze recycling method. Assay mixtures contain the gamma-glutamyl transpeptidase (GGT) inhibitor acivicin in order to prevent the degradation of gamma-glutamylcysteine and of the accumulating GSH, and dithiothreitol in order to prevent the oxidation of cysteine and gamma-glutamylcysteine. gamma-GCS and GS levels determined by this method are comparable to those determined by others. The method is suitable for the rapid determination of gamma-GCS GS in GGT-containing tissues and for the studies of induction of gamma-GCS and GS in tissue cultures.     

Dual specificity of su+7 tRNA. Evidence for translational discrimination

The su⁺7 amber suppressor of Escherichia coli is a mutant tRNA^Trp that translates UAG codons as glutamine. Nevertheless, the purified su⁺7 tRNA can be charged with either glutamine or tryptophan. Aminoacylation kinetics in vitro suggest that the tRNA should be acylated with equal amounts of glutamine and tryptophan in vivo. The predominance of the glutamine specificity of the suppressor is therefore potentially anomalous. We can find no selective deacylation of tryptophanyl-su⁺7 tRNA by glutaminyl-tRNA synthetase, tryptophanyl-tRNA synthetase, or any other cellular element. Furthermore, as predicted, nearly equal amounts of glutaminyl and tryptophanyl-su⁺7 tRNA are actually detected in aminoacyl-tRNA extracted from growing cells. We conclude that the translational apparatus somehow discriminates against tryptophanyl-su⁺7 tRNA at a step after synthesis of the two aminoacyl-tRNAs.     

Crystal structure of the archaeal asparagine synthetase: interrelation with aspartyl-tRNA and asparaginyl-tRNA synthetases

Asparagine synthetase A (AsnA) catalyzes asparagine synthesis using aspartate, ATP, and ammonia as substrates. Asparagine is formed in two steps: the β-carboxylate group of aspartate is first activated by ATP to form an aminoacyl-AMP before its amidation by a nucleophilic attack with an ammonium ion. Interestingly, this mechanism of amino acid activation resembles that used by aminoacyl-tRNA synthetases, which first activate the α-carboxylate group of the amino acid to form also an aminoacyl-AMP before they transfer the activated amino acid onto the cognate tRNA. In a previous investigation, we have shown that the open reading frame of Pyrococcus abyssi annotated as asparaginyl-tRNA synthetase (AsnRS) 2 is, in fact, an archaeal asparagine synthetase A (AS-AR) that evolved from an ancestral aspartyl-tRNA synthetase (AspRS). We present here the crystal structure of this AS-AR. The fold of this protein is similar to that of bacterial AsnA and resembles the catalytic cores of AspRS and AsnRS. The high-resolution structures of AS-AR associated with its substrates and end-products help to understand the reaction mechanism of asparagine formation and release. A comparison of the catalytic core of AS-AR with those of archaeal AspRS and AsnRS and with that of bacterial AsnA reveals a strong conservation. This study uncovers how the active site of the ancestral AspRS rearranged throughout evolution to transform an enzyme activating the α-carboxylate group into an enzyme that is able to activate the β-carboxylate group of aspartate, which can react with ammonia instead of tRNA.     

Tyrosyl-tRNA synthetase forms a mononucleotide-binding fold

Tyrosyl-tRNA synthetase from Bacillus stearothermophilus is a dimeric molecule of approximately 90,000 M_r. The crystal structure originally reported by Irwin et al. (1976) has been re-interpreted using a new density-modification technique. The reinterpretation is confirmed by the complete amino acid sequence (D. Barker & (G. Winter, personal communication). The structure consists of an amino-terminal $\text{α}\text{β}$ domain, a domain containing five α-helices, and a region of 99 amino acids at the carboxyl terminus, which appears to be disordered. The re-interpretation reveals two new α-helices in the $\text{α}\text{β}$ domain, and some changes in chain connections. The strands of the β-sheet are in the order A, F, E, B, C, D, with A antiparallel to the others. The arrangement of strands B to F is topologically identical to arrangements found in many other proteins, including the first five strands of the sheet in the NAD-binding domain of the dehydrogenases. Strands B, C, D form a mononucleotide-binding fold.In the complex with tyrosyl adenylate (Rubin & Blow, 1981), an intermediate in the reaction catalysed by the enzyme, the adenine lies near the carboxyl-terminal end of strand F of the β-sheet, with the ribose between the ends of strands B and E. This is similar to the nicotinamide position in dehydrogenases. The tyrosine moiety occupies a pocket at one side of the sheet, close to strands B and C. This tyrosine orientation is quite different from any part of the coenzyme in dehydrogenases. The ends of strands C and D of the sheet are buried, and binding of a nucleotide to the mononucleotide-binding fold formed by strands B, C, D would require a substantial structural change.     

Chloroplastic and cytoplasmic valyl- and leucyl- tRNA synthetases from Euglena gracilis: Comparative study of their structural properties

Chloroplastic and cytoplasmic valyl- and leucyl-tRNA synthetases purified from Euglena gracilis show a monomeric structure. The molecular weights of the two valyl-tRNA synthetases are identical (126 000) while those of the leucyl-tRNA synthetases are different (100 000 for the chloroplastic and 116 000 for the cytoplasmic enzyme). The tryptic maps and the amino acid compositions reveal differences between the chloroplastic valyl- and leucyl-tRNA synthetases and their cytoplasmic homologues. These results suggest that a chloroplastic aminoacyl-tRNA synthetase and its cytoplasmic counterpart are coded for by distinct genes.